Vanguard Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $94.6M | Buy |
|
|||||
|
2019
Q4 | $87.8M | Buy |
|
|||||
|
2019
Q3 | $43M | Buy |
|
|||||
|
2019
Q2 | $47M | Buy |
|
|||||
|
2019
Q1 | $29.3M | Buy |
|
|||||
|
2018
Q4 | $19.7M | Buy |
|
|||||
|
2018
Q3 | $13.4M | Buy |
|
|||||
|
2018
Q2 | $6.74M | Buy |
|
|||||
|
2018
Q1 | $3.56M | Buy |
|
|||||
|
2017
Q4 | $3.33M | Buy |
|
|||||
|
2017
Q3 | $5.21M | Buy |
|
|||||
|
2017
Q2 | $6.5M | Buy |
|
|||||
|
2017
Q1 | $5.75M | Buy |
|
|||||
|
2016
Q4 | $1.51M | Buy |
|